Amrize (NYSE:AMRZ) Stock Rating Raised to “Hold” at Barclays

Amrize (NYSE:AMRZ) was upgraded by equities researchers at Barclays to a “hold” rating in a research note issued on Thursday, Zacks reports.

A number of other brokerages have also issued reports on AMRZ. Weiss Ratings lowered shares of Amrize from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, August 31st. Wells Fargo & Company reissued an “equal weight” rating and issued a $44.00 price target (down from $55.00) on shares of Amrize in a report on Wednesday, September 9th. Citigroup cut shares of Amrize from a “buy” rating to a “cautious” rating in a research report on Wednesday, September 9th. Bank of America reiterated an “underperform” rating and issued a $40.00 price objective (down from $50.00) on shares of Amrize in a research report on Wednesday, September 2nd. Finally, DA Davidson initiated coverage on Amrize in a research report on Monday, August 24th. They issued a “neutral” rating and a $50.00 price objective on the stock. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eight have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $53.24.

Amrize Stock Down 0.4%

AMRZ opened at $37.24 on Thursday. The firm’s 50-day simple moving average is $43.88 and its 200-day simple moving average is $50.20. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10. Amrize has a twelve month low of $36.55 and a twelve month high of $65.94. The firm has a market cap of $20.60 billion, a price-to-earnings ratio of 17.16, a PEG ratio of 1.31 and a beta of 0.21.

Amrize (NYSE:AMRZ) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). The business had revenue of $3.49 billion during the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. Equities research analysts anticipate that Amrize will post 2.46 EPS for the current fiscal year.

Insider Transactions at Amrize

In other Amrize news, Director Jacques Sanche acquired 4,150 shares of the business’s stock in a transaction dated Wednesday, August 26th. The shares were acquired at an average price of $45.02 per share, for a total transaction of $186,833.00. Following the acquisition, the director directly owned 9,766 shares of the company’s stock, valued at approximately $439,665.32. This trade represents a 73.90% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Jan Jenisch acquired 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 2nd. The stock was acquired at an average price of $42.50 per share, with a total value of $170,000.00. Following the completion of the transaction, the chief executive officer directly owned 519,000 shares in the company, valued at $22,057,500. This trade represents a 0.78% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have purchased 48,983 shares of company stock valued at $2,158,755. Corporate insiders own 0.54% of the company’s stock.

Hedge Funds Weigh In On Amrize

Large investors have recently added to or reduced their stakes in the company. MCF Advisors LLC bought a new stake in Amrize during the fourth quarter worth $27,000. Continuum Advisory LLC acquired a new position in shares of Amrize during the 2nd quarter worth about $62,000. NewEdge Advisors LLC increased its stake in shares of Amrize by 1,419.7% during the 2nd quarter. NewEdge Advisors LLC now owns 2,082 shares of the company’s stock worth $111,000 after purchasing an additional 1,945 shares during the last quarter. Oslo Pensjonsforsikring AS bought a new stake in shares of Amrize in the 1st quarter valued at about $133,000. Finally, Caldwell Sutter Capital Inc. lifted its stake in Amrize by 11.5% in the 1st quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company’s stock valued at $150,000 after purchasing an additional 275 shares during the last quarter.

About Amrize

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.